AI in Neuroscience: Partnering with DANNCE.AI to Increase Drug Efficacy & Improve the Lives of People with Movement Disorders

AI in Neuroscience: Partnering with DANNCE.AI to Increase Drug Efficacy & Improve the Lives of People with Movement Disorders

DANNCE.AI is bringing to market a novel phenotyping platform to digitize the clinical assessments used by clinicians and drug developers to quantify movement. We led their $2.6M pre-seed round along with co-investors Glasswing Ventures, The Leo Lion Company, Duke Capital Partners, and Merck Digital Sciences Studio.

Read More

The FDA-Cleared Cionic Neural Sleeve Overcomes Disability in Real-Time

The FDA-Cleared Cionic Neural Sleeve Overcomes Disability in Real-Time

Meet Jeremiah Robison, Founder and CEO of CIONIC – one of LDV Capital’s portfolio companies. He has a 25-year career spent at the intersection of computing and the human body. At CIONIC, he builds robotic suits to help people move. For Jeremiah, it’s a truly personal story: his daughter’s CP diagnosis fueled a mission to empower all those with mobility impairments to move with more freedom and control.

Read More